Xiang Xiao Selected Research

Triglycerides (Triacylglycerol)

10/2019	Anti-obesity Action of Fermented Barley Extracts with Lactobacillus plantarum dy-1 and Associated MicroRNA Expression in High-fat Diet-induced Obese Rats.
4/2018	Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice.
12/2016	Dietary supplementation with Lactobacillus plantarum dy-1 fermented barley suppresses body weight gain in high-fat diet-induced obese rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiang Xiao Research Topics

Disease

16	Neoplasms (Cancer) 09/2021 - 06/2009
9	Body Weight (Weight, Body) 01/2021 - 09/2010
8	Obesity 08/2022 - 03/2017
8	Inflammation (Inflammations) 01/2022 - 01/2012
4	Ischemic Stroke 04/2016 - 01/2012
4	Stroke (Strokes) 10/2015 - 01/2012
4	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 11/2013 - 02/2012
3	Ischemia 01/2021 - 01/2012
3	Hypertension (High Blood Pressure) 01/2020 - 01/2019
3	Vascular Diseases (Vascular Disease) 09/2017 - 01/2015
3	Behcet Syndrome (Behcet's Syndrome) 01/2016 - 08/2012
3	Infarction (Infarctions) 10/2015 - 01/2012
2	Glucose Intolerance 08/2022 - 12/2016
2	Osteoarthritis 06/2022 - 01/2022
2	Kashin-Beck Disease 06/2022 - 01/2022
2	Fibrosis (Cirrhosis) 06/2022 - 06/2016
2	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2018
2	Infections 01/2022 - 03/2021
2	Pneumonia (Pneumonitis) 07/2021 - 01/2018
2	Autism Spectrum Disorder 04/2020 - 01/2020
2	Cysts 10/2018 - 06/2005
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 01/2018
2	Overweight 01/2018 - 03/2013
2	Hypoxia (Hypoxemia) 01/2017 - 01/2013
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 10/2015
2	Shock 12/2016 - 04/2006
2	Seizures (Absence Seizure) 01/2009 - 01/2008
1	Dyslipidemias (Dyslipidemia) 06/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Multiple Myeloma 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Weight Gain 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Hemorrhage 11/2021
1	Acute Coronary Syndrome 11/2021

Drug/Important Bio-Agent (IBA)

9	LipidsIBA 08/2022 - 03/2017
7	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2013
6	erucylphosphocholineIBA 09/2017 - 01/2012
5	Indicators and Reagents (Reagents)IBA 06/2021 - 01/2015
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2017
3	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2012
3	Therapeutic UsesIBA 01/2021 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2020 - 05/2012
3	Triglycerides (Triacylglycerol)IBA 10/2019 - 12/2016
3	Oxygen (Dioxygen)IBA 09/2010 - 01/2008
2	Insulin (Novolin)FDA Link 08/2022 - 04/2018
2	Interleukin-7 (Interleukin 7)IBA 01/2022 - 02/2012
2	ORALIT (ORS)IBA 01/2022 - 01/2017
2	C-Reactive ProteinIBA 01/2022 - 01/2012
2	CytokinesIBA 01/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2016
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 12/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021 - 01/2016
2	GlucansIBA 11/2020 - 03/2017
2	spleen fibrinolytic proteinase (human) (SFP)IBA 04/2020 - 01/2020
2	AntigensIBA 01/2020 - 01/2020
2	CholesterolIBA 10/2019 - 12/2016
2	Air Pollutants (Pollutants, Air)IBA 01/2019 - 01/2018
2	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 05/2012
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 02/2012
2	LigandsIBA 01/2016 - 05/2012
2	Interleukin-17 (Interleukin 17)IBA 01/2016 - 07/2012
2	angiotensin I (1-7)IBA 10/2015 - 03/2013
2	Angiotensin IIIBA 01/2014 - 03/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2012 - 05/2012
1	PowdersIBA 08/2022
1	SeleniumIBA 06/2022
1	Chemotactic FactorsIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	DNA Restriction-Modification Enzymes (Restriction Modification Systems)IBA 01/2022
1	alpha-SynucleinIBA 01/2022
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	InterferonsIBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 11/2021
1	Hematoxylin (Haematoxylon)IBA 11/2021
1	AnticoagulantsIBA 11/2021
1	bivalirudin (Angiomax)FDA Link 11/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2021

Therapy/Procedure

8	Therapeutics 01/2021 - 03/2013
3	Transplantation 09/2017 - 10/2015
2	Percutaneous Coronary Intervention 11/2021 - 09/2021
2	Drug Therapy (Chemotherapy) 07/2019 - 01/2018
1	Stents 11/2021